OUR NUTRIENT DRUG CONJUGATE TECHNOLOGY (NDCt)™
- turns parenteral compounds into oral variants or improves oral
bioavailability.
- uses specific transporter proteins for food, i.e. active transport over the gut wall.
- delivers tailor made solutions with our toolbox of linkers and nutrient.
PATIENTS BENEFITS:
- Oral administration is by far the preferred route and GI side effects may diminish, both improving compliance and with that efficacy
- Enhanced bioavailability gives less inter-patient variability
- New indications for the same compound
BENEFITS TO COMPANIES:
- Life cycle management from an NCE (new IP, often COM).
- Short route to approval.
- NDCt platform broadly applicable, irrespective of disease area.
- Accelerate development of pipeline products.
- Once promising, but now shelved research, can be revived.
NDCt GIVES CONTROL OVER THE COMPOUND
We chemically attach a nutrient mimic via a linker to the drug. The linker has profound effects on transport and synthesis.
The nutrient mimic is a transporter substrate – recognized by the intestinal wall – facilitating active transport (vs passive transport of old-fashioned drugs).
Subsequent enzymatic cleavage in the bloodstream, liberating the drug.
With our patented NDCt we address the full spectrum of issues around oral bioavailability and control the compound.
PROVIDING THE MISSING LINK
PharmaCytics developed a toolbox of proprietary linkers and nutrient mimics.
With our bifunctional linker variants it is even possible to couple drugs to biomolecules, such as proteins and antibodies.
In addition, our linker technology can produce mutual prodrugs (or codrugs) in which two different synergistic acting pharmacological agents are linked together.
LET US REVIVE HIDDEN TREASURES IN YOUR PIPELINE
PharmaCytics brings in its expertise on medicinal chemistry, prodrug technology and drug delivery to solve and improve on your drug development issues.
CALL US AND CHALLENGE US!
Company Details
- Employees
- 6
- Founded
- -
- Address
- Transistorweg 5 V, Nijmegen,gelderland 6534at,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pharmacytics.com
- Keywords
- organic synthesis, organic chemistry, pharmaceutical development, partnership, life cycle extension, patent extension, active gut transport, bioavailability, specific transporter proteins, small molecules.
- HQ
- Nijmegen, Gelderland
Pharmacytics Questions
Pharmacytics's website is pharmacytics.com
Pharmacytics's LinkedIn profile is https://nl.linkedin.com/company/pharmacytics
Pharmacytics has
6 employees.
View email and phone details for 6
employees at Pharmacytics.
Pharmacytics's industry is
Pharmaceutical Manufacturing
Pharmacytics's top competitors are
Protinhi Therapeutics,
Chemconnection B.v.,
Tagworks Pharmaceuticals,
Northsea Therapeutics,
Polar Nanopharma,
Khondrion,
Avivia,
Regen Biomedical,
Byondis,
Orca Therapeutics.
Pharmacytics's categories are Pharmaceutical Manufacturing
Pharmacytics's founding year is 2015
